| Decision modelling for health economic evaluation A Briggs, M Sculpher, K Claxton Oup Oxford, 2006 | 3934 | 2006 |
| Consolidated health economic evaluation reporting standards (CHEERS) statement D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ... Bmj 346, 2013 | 3247 | 2013 |
| Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good … D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ... Value in health 16 (2), 231-250, 2013 | 2138 | 2013 |
| Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ... MDM Policy & Practice 7 (1), 23814683211061097, 2022 | 1378 | 2022 |
| Modeling good research practices—overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1 JJ Caro, AH Briggs, U Siebert, KM Kuntz Medical Decision Making 32 (5), 667-677, 2012 | 1265 | 2012 |
| An introduction to Markov modelling for economic evaluation A Briggs, M Sculpher Pharmacoeconomics 13 (4), 397-409, 1998 | 1256 | 1998 |
| Cost‐effectiveness acceptability curves–facts, fallacies and frequently asked questions E Fenwick, BJ O'Brien, A Briggs Health economics 13 (5), 405-415, 2004 | 1080 | 2004 |
| Pulling cost‐effectiveness analysis up by its bootstraps: a non‐parametric approach to confidence interval estimation AH Briggs, DE Wonderling, CZ Mooney Health economics 6 (4), 327-340, 1997 | 1010 | 1997 |
| Handling uncertainty in cost-effectiveness models AH Briggs Pharmacoeconomics 17, 479-500, 2000 | 1008 | 2000 |
| Prognosis Research Strategy (PROGRESS) 2: prognostic factor research RD Riley, JA Hayden, EW Steyerberg, KGM Moons, K Abrams, PA Kyzas, ... PLoS medicine 10 (2), e1001380, 2013 | 867 | 2013 |
| Review of statistical methods for analysing healthcare resources and costs B Mihaylova, A Briggs, A O'Hagan, SG Thompson Health economics 20 (8), 897-916, 2011 | 847 | 2011 |
| Good research practices for cost‐effectiveness analysis alongside clinical trials: the ISPOR RCT‐CEA Task Force report S Ramsey, R Willke, A Briggs, R Brown, M Buxton, A Chawla, J Cook, ... Value in health 8 (5), 521-533, 2005 | 817 | 2005 |
| Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report SD Ramsey, RJ Willke, H Glick, SD Reed, F Augustovski, B Jonsson, ... Value in health 18 (2), 161-172, 2015 | 809 | 2015 |
| Oral versus intravenous antibiotics for bone and joint infection HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ... New England Journal of Medicine 380 (5), 425-436, 2019 | 803 | 2019 |
| Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Medical decision making 32 (5), 722-732, 2012 | 800 | 2012 |
| A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ... Diabetologia 47, 1747-1759, 2004 | 794 | 2004 |
| Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Value in Health 15 (6), 835-842, 2012 | 787 | 2012 |
| Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes H Hemingway, P Croft, P Perel, JA Hayden, K Abrams, A Timmis, A Briggs, ... Bmj 346, 2013 | 714 | 2013 |
| Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis A Briggs, M Sculpher, M Buxton Health economics 3 (2), 95-104, 1994 | 668 | 1994 |
| Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis JS Hoch, AH Briggs, AR Willan Health economics 11 (5), 415-430, 2002 | 641 | 2002 |